Search for: "Hoffman La-Roche Inc."
Results 61 - 80
of 131
Sorted by Relevance
|
Sort by Date
12 Aug 2022, 6:48 pm
Hoffman-La Roche Ltd, 580 F.3d 1340, 1365–67 (Fed. [read post]
3 May 2011, 10:20 am
Hoffman-La Roche, Inc., 585 S.E.2d 723, 727 (Ga. [read post]
17 Aug 2011, 8:01 am
Among the highlights: There’s an interesting press release that looks like it comes from Littler Mendelson announcing that Littler has filed a mandamus petition on behalf of one of its clients, HCR ManorCare, seeking to persuade the Sixth Circuit to hold that the entire certification process described by Hoffman-La Roche, Inc. [read post]
14 Aug 2008, 7:22 pm
Hoffman-La Roche Ltd. v. [read post]
4 Sep 2013, 3:32 am
Hoffman-La Roche Inc., 541 F.3d 1115, 1121, 1124 (Fed. [read post]
4 Oct 2010, 4:30 am
Hoffman-La Roche, Inc., No. [read post]
11 Jan 2016, 7:10 am
Hoffman-La Roche, a 1985 New Jersey Supreme Court opinion. [read post]
27 Dec 2016, 6:29 am
Although section 16(b) of the FLSA was passed to limit collective actions, Hoffman-La Roche v. [read post]
22 Mar 2011, 4:21 pm
Brownback’s 2010 version (FDA Law Blog) US: Effective March 28, 2011 – New safety reporting requirements for certain drug and biological products (FDA Law Blog) US: FDA issues new guidance on PDUFA user fee waivers, reductions, and refunds; guidance represents the culmination of 18 years of FDA experience (FDA Law Blog) US: Affymetrix files for correction of inventorship: Affymetrix v Illumina (Patent Docs) US: Hoffman-La Roche files for review and correction… [read post]
14 Jan 2014, 9:30 am
Hoffman-La Roche Limited v. [read post]
19 Mar 2014, 9:00 am
In 2000, Amgen’s recombinant EPO patent (for EPREX, which stimulates red blood cells to treat anaemia) was found valid and infringed by Hoffman’s RECORMON product.[1] In January 2014 the Federal Court once again upheld the validity of certain claims of Abbott’s psoriasis antibody patent that were challenged by Janssen[2]. [read post]
12 Apr 2011, 3:50 pm
Hoffman-La Roche, Inc., 2009 WL 614484, *23 (N.J.Super.A.D. 2009). [read post]
29 Mar 2007, 4:46 am
Hoffman-La Roche, Inc., ___ A.2d ___, 2007 WL 923512 (N.J. [read post]
17 Dec 2011, 9:05 am
Citigroup Inc. [read post]
7 Oct 2013, 11:06 am
Hoffman-LA Roche Ltd., 580 F.3d 1340, 1362 (Fed. [read post]
21 Feb 2014, 8:53 am
Mylan, Inc., 911 F. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against APP Pharmaceuticals following Para… [read post]
1 Feb 2016, 8:11 am
Hoffman-La Roche Ltd., 580 F.3d 1340 (Fed. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
